ea0037ep734 | Pituitary: clinical | ECE2015
van Bunderen Christa C.
, Lips Paul
, Kramer Mark H.
, Drent Madeleine L.
Introduction: The current guidelines state that the goals of growth hormone (GH) therapy should be an appropriate clinical response and avoidance of side effects. The target level for IGF1 is commonly the upper half of the reference range, although no published studies offer specific guidance in this regard. Therefore, the aim of the present study is to investigate associations between IGF1 levels within the reference range and several efficacy and safety measures of GH treatm...